• May 13, 2026 9:48 am

Bandhan Healthcare Fund NFO: Invest in India’s Healthcare Growth Story

Bandhan Healthcare Fund has announced an exciting New Fund Offer (NFO) open from November 10 to November 24, 2025, giving investors a chance to ride the wave of India’s rapidly expanding healthcare sector.​

NFO Highlights

  • Subscription window: November 10–24, 2025​

  • Minimum investment: ₹1,000 for lumpsum, SIP starts at ₹100​

  • Scheme type: Open-ended equity scheme, focused on healthcare, pharma, and allied services​

  • Benchmark: BSE Healthcare TRI​

  • Exit load: 0.50% if redeemed within 30 days, nil thereafter​

  • Fund managers: Viraj Kulkarni (Equity), Brijesh Shah (Debt)​

Investment Strategy

The fund will invest across the entire healthcare value chain, including hospitals, diagnostics, pharmaceutical exports, CDMO/API, and branded domestic formulations. By maintaining a balanced allocation across four major themes, the fund aims to benefit from diverse growth triggers such as increasing insurance coverage, rising healthcare demand, and innovation in medicine and technology.​

Who Should Invest?

This NFO is ideal for investors with a long-term horizon seeking exposure to a sector backed by strong growth potential, demographic trends, and defensive characteristics. The healthcare sector’s resilience and evolving business models make it attractive for those willing to embrace short-term volatility in pursuit of long-term capital appreciation.​

Bandhan Healthcare Fund offers a focused opportunity to capitalize on India’s healthcare transformation. Investors are advised to review scheme documents or consult a financial advisor to ensure suitability for their risk appetite and investment goals.

Thematic and Long-Term Growth Focus

  • The fund leverages key trends such as aging demographics, increased insurance penetration, medical innovation, and rising healthcare spending as its investment backbone.​

  • Its allocation strategy helps mitigate risk by avoiding concentration in any single sub-sector, while the active management aims to outperform passive sector indices.​

  • The research focus includes therapy area growth, capacity expansion, strong brand recall, quality regulatory track record, and robust financial strength for selected stocks.​

  • The use of the BSE Healthcare TRI as its benchmark ensures sector alignment and relevant performance measurement.​

This thematic NFO is designed for investors seeking diversified exposure to India’s healthcare transformation, supported by rigorous research and active portfolio management.​

 
 
 
 

Leave a Reply

Your email address will not be published. Required fields are marked *